Amicus Therapeutics Inc (NASDAQ:FOLD)

Delayed Data
As of Mar 23
 -0.07 / -0.50%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 19.50, with a high estimate of 22.00 and a low estimate of 17.00. The median estimate represents a +38.69% increase from the last price of 14.06.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.95%
Growthannually 23.60%


Growthquarterly 12.31%
Growthannually 133.39%
Key to the earnings and sales forecast charts.